Stockreport

BioAtla: Numerous Catalysts Coming In Q4 [Seeking Alpha]

BioAtla, Inc.  (BCAB) 
PDF 10min Summary BioAtla, Inc. has promising pipeline projects, including masked antibodies and ADCs targeting AXL and ROR2, showing early efficacy and potential for i [Read more]